Imprimis NJOF Recalls Intraocular Injection Due to Glass Particles
Imprimis NJOF, LLC recalled 778 boxes of Dexamethasone Moxifloxacin intraocular injection on December 18, 2025. The recall stems from the presence of glass-like particles in the product. Consumers and healthcare providers should stop using the product immediately.


